about
Considerations for observational research using large data sets in radiation oncologyDetecting Lung and Colorectal Cancer Recurrence Using Structured Clinical/Administrative Data to Enable Outcomes Research and Population Health Management.The accuracy and completeness for receipt of colorectal cancer care using Veterans Health Administration administrative data.A Validation Study of Administrative Claims Data to Measure Ovarian Cancer Recurrence and Secondary Debulking Surgery.Utility of administrative claims data for the study of brain metastases: a validation study.The effect of hospital and surgeon volume on racial differences in recurrence-free survival after radical prostatectomy.Early discontinuation of endocrine therapy for breast cancer: who is at risk in clinical practice?Comparing methods for identifying pancreatic cancer patients using electronic data sources.Preoperative breast MRI and surgical outcomes in elderly women with invasive ductal and lobular carcinoma: a population-based study.Population-based longitudinal study of follow-up care for breast cancer survivorsAdjuvant external beam radiation for medullary thyroid carcinoma.Tradeoffs between accuracy measures for electronic health care data algorithmsValidation of electronic data on chemotherapy and hormone therapy use in HMOs.Administrative data algorithms to identify second breast cancer events following early-stage invasive breast cancerA comparison of the effects of epidural analgesia versus traditional pain management on outcomes after gastric cancer resection: a population-based study.Unsupported off-label chemotherapy in metastatic colon cancer.Prognostic factors for survival in patients with epithelioid sarcoma: 441 cases from the SEER database.Classification and sequential pattern analysis for improving managerial efficiency and providing better medical service in public healthcare centersThe diffusion of docetaxel in patients with metastatic prostate cancerAn algorithm to identify the development of lymphedema after breast cancer treatment.Development of a claims-based algorithm to identify colorectal cancer recurrence.Management of malignant colonic polyps: a population-based analysis of colonoscopic polypectomy versus surgery.Addition of rituximab to chemotherapy alone as first-line therapy improves overall survival in elderly patients with mantle cell lymphomaInfused therapy and survival in older patients diagnosed with metastatic breast cancer who received trastuzumab.Evaluation of record linkage between a large healthcare provider and the Utah Population Database.Challenges and opportunities in measuring cancer recurrence in the United StatesEnd-of-Life Care Intensity Among Adolescent and Young Adult Patients With Cancer in Kaiser Permanente Southern California.Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer.Validating billing/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using 2 large contemporary cohortsGeographic variation in physicians' responses to a reimbursement change.Skeletal Plasmacytoma: progression of disease and impact of local treatment; an analysis of SEER database.Survival impact of followup care after radical cystectomy for bladder cancer.Record linkage for pharmacoepidemiological studies in cancer patients.Sensitivity of Medicare Claims to Identify Cancer Recurrence in Elderly Colorectal and Breast Cancer Patients.Care in the Final Month of Life among Adolescent and Young Adult Cancer Patients in Kaiser Permanente Southern California.Outcomes after endoscopic versus surgical therapy for early esophageal cancers in an older population.Comparative outcomes of rituximab-based systemic therapy and splenectomy in splenic marginal zone lymphoma.Limited stage diffuse large B-cell lymphoma: comparative effectiveness of treatment strategies in a large cohort of elderly patients.Disparate survival outcomes after front-line chemoimmunotherapy in older patients with follicular, nodal marginal zone and small lymphocytic lymphoma.Physician Agency and Patient Survival.
P2860
Q24289442-7E46F246-CAA5-46C8-A17A-76E189180DF5Q30983918-F583F5D9-2DE7-4B31-9639-3CA75E7C66E2Q31044526-97E12232-63FD-46F0-BC1D-547CC48846C4Q31144976-A4F840D9-82E4-433F-9DDB-407272B3ED25Q33475683-6A48E313-8CCE-4B91-9B80-4B280482FA79Q33610497-AEBAF145-9B8C-46E7-AE98-D2A1E29136D4Q33756969-FC6C493C-B8FE-4566-A72E-8AD07FD39723Q33828084-0E13F24C-A868-47B5-8357-BF3B08ECE84DQ33887565-45DE0125-88F0-492C-B3DE-4708D038E4CAQ33978894-4CACA538-9D46-438A-B13F-70D12D957ED0Q34015508-121975D8-1229-4415-AC83-CB81EA4BB31BQ34111706-C5E1F71F-F3DF-4783-85EB-09A58297E7FCQ34244526-0580DB09-7E0E-41C2-807F-40A992EEB5FDQ34252411-64CED984-7D6B-4E4D-A7F7-EB969ADEBB74Q34314998-199E51DE-9DBF-4E28-A2B9-33369F4F0BB3Q34526503-10D7F8B4-31A5-49EB-9CC4-F9A2DDBA626DQ34947326-5213873A-8890-40D0-967C-65A3D6A4E8ACQ34951731-C93E841A-6F3B-4F7F-B5EC-11F165E4ACFEQ35078581-89486681-232F-4742-B1DF-45E0DA789A83Q35185438-BCA1EBFC-912E-4D20-B3DC-F50DB961389CQ35205035-25A09C4E-4D59-4B5A-B7A2-7DE5EB425EC0Q35349589-277C279A-8B8D-438A-9D08-503630F14426Q35525522-AC467543-2E2B-4150-BBCF-6523C6556F0FQ35540696-1B7E3201-06BE-41DD-A2E8-C7A8EDF6A9DEQ36085133-8D1B805F-224A-4073-B12E-A906E1CF0D4CQ36087206-BE75D3CF-4BC3-4017-B320-AC15B2CEB24EQ36206752-B6ECAE35-A0A4-4859-A16D-4018690D7F69Q36292773-B76763E5-F995-4429-B60C-A3539DD3EC9CQ36692575-EB165862-48A0-4F95-A9C5-FA4866E553BCQ36892648-28039E62-BACD-451C-9980-060DCCF6F873Q37382510-3470C99F-CF51-4132-826A-64F65EED8B3EQ37495636-65277394-8F51-4CAC-9F17-E9309F9EFF3DQ37910845-AF501DE9-1A17-403C-89FF-67CC18B98D4CQ38174422-868601C7-BC35-4681-A2F1-8C2F9D7BEBBBQ38915981-D4601C6C-11B6-443F-89FD-255483290EEEQ40071822-3A1964A4-6E25-41D4-A34E-C932F5AE9A6FQ44628624-FB1E78D0-5AB4-44D5-96FC-3C575967F012Q45174932-1754A573-5CC9-465D-8C91-6495B4649480Q53039853-EA11117F-1099-40DE-81A0-C50B296042A8Q54106023-901060B3-D2FE-402F-A17C-1408E7961638
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Identifying cancer relapse using SEER-Medicare data.
@ast
Identifying cancer relapse using SEER-Medicare data.
@en
type
label
Identifying cancer relapse using SEER-Medicare data.
@ast
Identifying cancer relapse using SEER-Medicare data.
@en
prefLabel
Identifying cancer relapse using SEER-Medicare data.
@ast
Identifying cancer relapse using SEER-Medicare data.
@en
P2093
P1433
P1476
Identifying cancer relapse using SEER-Medicare data.
@en
P2093
Ann B Nattinger
Arnold L Potosky
Craig C Earle
Joan L Warren
Kathleen Lang
Mark Berger
Rajiv Mallick
P304
P356
10.1097/00005650-200208001-00011
P433
P577
2002-08-01T00:00:00Z